NCIMMUNE LEADING EARLY CANCER DETECTION

Early detection may be your best chance for surviving lung cancer.

The Facts:

  • Worldwide, nearly 1.83 million new cases of lung cancer were estimated to have been diagnosed in 2012, with incidence rates varying across the world.1
  • Lung cancer is the most common cause of cancer death worldwide, with around 1,590,000 deaths from lung cancer in 2012 (19% of the total).
  • The 5-year survival rate is only 17.7%2
  • Almost 80% of lung cancer is diagnosed after spread to other organs2
  • 56% of patients perish in the 1st year after diagnosis3
  • As NIH data show, when found early, while still localized, the 5-year survival rate for lung cancer more than triples to 55%.2

As reported in the landmark US National Lung Cancer Screening Trials study (NLST) published in the New England Journal of Medicine in July 2011, early detection enabled by low-dose CT scans resulted in a 20% reduction in lung cancer mortality.

Annual low-dose CT scanning (LDCT) is now an approved method of lung cancer screening in the US with associated reimbursement. BUT only if you meet the strict criteria published by the USPSTF guidelines4, derived from the National Lung Screening Trial (NLST): age 55-80, current or ex smoker (cessation within 15 years) and 30 pack year history.

As a simple blood test, EarlyCDT-Lung can be used when a patient is at increased risk of lung cancer but does not meet the criteria for annual CT screening. In addition, some patients are unwilling or unable to commit to annual CT scanning.

http://www.cancerresearchuk.org/health-professional/cancer-statistics
2 Howlader N, Noone AM, Krapcho M et al. SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/lungb.html based on November 2015 SEER data submission, posted to the SEER web site, April 2016.
3 American Cancer Society, Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015
http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/lung-cancer-screening

How common is lung cancer in the USA?1

  • Lung cancer remains the number one cancer killer on the USA
  • 158,000 deaths from lung cancer in the US in 2016
  • 224,000 new cases of lung cancer diagnosed in the USA in 2014
  • Approximately 42 million smokers in the USA

http://seer.cancer.gov/statfacts/html/lungb.html

How common is lung cancer in Europe and the UK?1

  • Lung cancer is the most common cause of cancer death in Europe, with around nearly 354,000 deaths from lung cancer in 2012 (20% of the total).
  • 45,525 new cases of lung cancer in the UK in 2013
  • 35,895 deaths from lung cancer in the UK in 2014
  • 13% of total cancer cases in the UK were lung cancer in 2013

http://www.cancerresearchuk.org/health-professional/cancer-statistics

How common is lung cancer in Asia?1

  • 51 percent of the world’s lung cancer cases occur in Asia
  • 21 percent of cancer deaths in Asia are due to lung cancer
  • China is the largest consumer of tobacco in the world with about 301 million current smokers
  • About two-thirds of young Chinese men smoke, and estimates indicate half of them will die as a result of smoking if they don’t quit
  • Smoking deaths in China are estimated to be around 2 million in 2030 and are expected to triple by 2050 to 3 million people a year – more than the population of Chicago

1 https://www.iaslc.org/lung-cancer-fact-sheet-2016-asia

PLEASE READ THE FOLLOWING STATEMENT CAREFULLY

Electronic versions of the materials you are seeking to access are being made available on this website by Oncimmune Holdings plc (the “Company”).

These materials are not directed to nor are they intended for access by persons located or resident in the United States, Australia, Canada, South Africa, Japan or any other jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.

None of the securities of Company discussed or referred to in the materials you are seeking to access have been registered under the US Securities Act or 1933, as amended (the “Securities Act”) and may not be offered, sold, pledged or otherwise transferred except (1) in an offshore transaction meeting the requirements of Rule 903 or Rule 904 of Regulation S under the Securities Act, (2) pursuant to an effective registration statement under the Securities Act, or (3) pursuant to an available exemption from the registration requirements of the Securities Act, in each case in accordance with all applicable securities laws.

By clicking the “SUBMIT” button below you confirm that you (1) have read and understood the information set out above, (2) agree to be bound by its terms, (3) are not located in the United States and do not have a registered address in, and are not resident or located in, Australia, Canada, South Africa or Japan and (4) are permitted under applicable law and regulation to proceed to the following parts of this website.

Please click on the button below to confirm that you have read, understood and agree with the disclaimer above.

Yes, I accept No, I don't accept